Haematologica
Real-world effectiveness and safety of belantamab mafodotin monotherapy in patients with relapsed/refractory multiple myeloma treated in Europe.
Michele Cavo, Fredrik Schjesvold, Meletios Dimopoulos, Michel Delforge, Fernando Escalante, David Kleinman, Hans C Lee, Ravi Vij, Richard Greil, Thomas Melchardt, Elisabetta Antonioli, Anna Lysen, Leena Camadoo-O'Byrne, Jacopo Bitetti, Tim D'Estrube
Published: 202610.3324/haematol.2025.289034
Abstract
Not available.